HANMIPHARM revenue breakdown overview

HANMIPHARM revenue for the last year amounted to 1.50 T KRW, the most of which — 1.10 T KRW — came from its highest performing source at the moment, Pharmaceutical Raw Materials, the year earlier bringing 1.09 T KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought HANMIPHARM 918.60 B KRW, and the year before that — 890.76 B KRW.